Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Woller

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Blood Advances|October 18, 2021
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialScott C Woller, Scott M Stevens, David Kaplan, et al.
Research and Practice in Thrombosis and Haemostasis|October 15, 2024
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolismScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Chest|May 17, 2014
Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolismScott C Woller, Scott M Stevens, Daniel M Adams, et al.
The American Journal of Cardiology|May 30, 2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial FibrillationVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Journal of the American Heart Association|July 13, 2016
Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other IndicationsT Jared Bunch, Heidi T May, Tami L Bair, et al.
Chest|March 8, 2024
Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.
Transplantation Direct|March 6, 2023
Performance of a Prospective Anticoagulation Stratification Algorithm After Liver TransplantationJorge Sanchez-Garcia, Fidel Lopez-Verdugo, Spencer LeCorchick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2014
Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolismScott C Woller, Scott M Stevens, Steven Towner, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Blood Advances|October 18, 2021
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialScott C Woller, Scott M Stevens, David Kaplan, et al.
Research and Practice in Thrombosis and Haemostasis|October 15, 2024
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolismScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Chest|May 17, 2014
Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolismScott C Woller, Scott M Stevens, Daniel M Adams, et al.
The American Journal of Cardiology|May 30, 2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial FibrillationVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Journal of the American Heart Association|July 13, 2016
Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other IndicationsT Jared Bunch, Heidi T May, Tami L Bair, et al.
Chest|March 8, 2024
Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.
Transplantation Direct|March 6, 2023
Performance of a Prospective Anticoagulation Stratification Algorithm After Liver TransplantationJorge Sanchez-Garcia, Fidel Lopez-Verdugo, Spencer LeCorchick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2014
Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolismScott C Woller, Scott M Stevens, Steven Towner, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Pageof 9